• Publications
  • Influence
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical TrialsExpand
  • 115
  • 2
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies KnowledgeExpand
  • 53
  • 2
Gateways to clinical trials. March 2003.
Gateways to clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledgeExpand
  • 16
  • 1
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical TrialsExpand
  • 65
Ciclesonide: Treatment of allergic rhinitis antiallergy/antiasthmatic
Acylation of (11β,16α)-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione (I) with isobutyric anhydride in pyridine gives the 16,17,21-triester (II), which is treated with cyclohexanecarbaldehydeExpand
  • 19
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the following tables have been retrieved from the Clinical Trials KnowledgeExpand
  • 25
Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril.
The aim of the present study was to determine whether or not the pharmacokinetic and hemodynamic response to a 20 mg single oral dose of lisinopril was sex-dependent. Thirty-two young healthyExpand
  • 10
Miglustat: Treatment of Gaucher's disease ceramide glucosyltransferase inhibitor α-glucosidase inhibitor
Glucosphingolipid (GSL) storage diseases are a family of inherited, metabolic, progressive, lysosomal storage disorders in which fatty glycosylated sphin-golipids accumulate in cells of the spleen,Expand
  • 9
Tecadenoson: Antiarrhythmic, adenosine A1 agonist
Adenosine has been shown to be a clinically effective antiarrhythmic agent. However, because it acts on all 4 adenosine cell surface receptors (AdoRs), in addition to the cardiovascular effectsExpand
  • 8
Aprepitant and L-758298: Antiemetic, antidepressant, tachykinin NK1 antagonist
Despite recent progress in the development of better tolerated and more effective treatments for controlling chemotherapy-induced nausea and vomiting, emesis continues to be problematic for manyExpand
  • 12